相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer
Feng Zhou et al.
CANCER (2012)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Circadian Rhythm Gene Period 3 Is an Inhibitor of the Adipocyte Cell Fate
Maria Jose Costa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer
Takashi Oshima et al.
ONCOLOGY REPORTS (2011)
The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral Clocks
Charna Dibner et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer
Chunhui Yi et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Per3, a circadian gene, is required for Chk2 activation in human cells
Jun-Sub Im et al.
FEBS LETTERS (2010)
High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma
Xin-Rong Yang et al.
GUT (2010)
CD151 Modulates Expression of Matrix Metalloproteinase 9 and Promotes Neoangiogenesis and Progression of Hepatocellular Carcinoma
Guo-Ming Shi et al.
HEPATOLOGY (2010)
Testing the Circadian Gene Hypothesis in Prostate Cancer: A Population-Based Case-Control Study
Yong Zhu et al.
CANCER RESEARCH (2009)
SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies
Zongli Xu et al.
NUCLEIC ACIDS RESEARCH (2009)
The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response
Aaron E. Hoffman et al.
MOLECULAR CANCER RESEARCH (2008)
Disturbance of Circadian Gene Expression in Hepatocellular Carcinoma
Yueh-Min Lin et al.
MOLECULAR CARCINOGENESIS (2008)
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk
Yong Zhu et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Carcinogenicity of shift-work, painting, and fire-fighting
Kurt Straif et al.
LANCET ONCOLOGY (2007)
Identification of common genetic variation that modulates alternative splicing
Jeremy Hull et al.
PLOS GENETICS (2007)
CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock
Jason P. DeBruyne et al.
NATURE NEUROSCIENCE (2007)
Ala394Thr polymorphism in the clock gene NPAS2: A circadian modifier for the risk of non-Hodgkin's lymphoma
Yong Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Transarterial chemoembolization for hepatocellular carcinoma
WY Lau et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2006)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Chemoembolization for hepatocellular carcinoma
J Bruix et al.
GASTROENTEROLOGY (2004)
BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced bv dimerization of transcriptional activators of the mammalian clock system
RV Kondratov et al.
GENES & DEVELOPMENT (2003)
The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo
LN Fu et al.
CELL (2002)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
A single nucleotide polymorphism at the splice donor site of the human MYH base excision repair gene results in reduced translation efficiency of its transcripts
S Yamaguchi et al.
GENES TO CELLS (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Posttranslational mechanisms regulate the mammalian circadian clock
C Lee et al.
CELL (2001)
Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock
BH Zheng et al.
CELL (2001)
分享论文
